Razoxane *

This publication has 10 references indexed in Scilit:

• Razoxane (ICRF 159) in the treatment of psoriasis
  British Journal of Dermatology, 1980
• ICRF 159, (±) 1,2-di(3,5-dioxopiperazin-1-yl)propane NSC-129,943; Razoxane
  Cancer Treatment Reviews, 1976
• The bioavailability in man of ICRF-159 a new oral antineoplastic agent
  Journal of Pharmacy and Pharmacology, 1975
• Determination of (±)‐1,2‐Bis(3,5‐dioxopiperazinyl) propane Plasma Levels in Rats, Rabbits, and Humans by GLC and Mass Fragmentography
  Journal of Pharmaceutical Sciences, 1975
• TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION
  The Journal of Experimental Medicine, 1972
• Angiogenesis in Psoriasis: Therapeutic Implications
  Journal of Investigative Dermatology, 1972
• Metastases and the Normalization of Tumour Blood Vessels by ICRF 159: A New Type of Drug Action
  BMJ, 1972
• Metabolic and ultrastructural studies in a patient with pustular psoriasis (von Zumbusch)
  Archives of Dermatology, 1972
• Mode of Action of the Cytostatic Agent ‘ICRF 159’
  Nature, 1970
• Control of Malignant Metastases by ICRF 159
  Nature, 1969